Standard BioTools Inc. Increase (Decrease) in Accounts Payable
Standard BioTools Inc. (LAB) reported Increase (Decrease) in Accounts Payable of $441.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- Standard BioTools Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $1.67M, a 17.58% increase year-over-year.
- Standard BioTools Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.22M.
- Standard BioTools Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $653.00K.
- Standard BioTools Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was $946.00K.
- Standard BioTools Inc. increase (decrease) in accounts payable for fiscal 2025 was $2.44M.
- Standard BioTools Inc. increase (decrease) in accounts payable for fiscal 2024 was -$12.97M, a 901.92% decline from fiscal 2023.
- Standard BioTools Inc. increase (decrease) in accounts payable for fiscal 2023 was $1.62M.
- Standard BioTools Inc. increase (decrease) in accounts payable for fiscal 2022 was -$2.78M, a 316.71% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $441.00K 10-Q · filed 2026-08-05 | $1.09M derived: sum of 3 quarters · filed 2026-08-05 | $2.04M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | -$1.22M 10-Q · filed 2026-05-06 | -$571.00K derived: sum of 2 quarters · filed 2026-05-06 | $375.00K derived: sum of 3 quarters · filed 2026-05-06 | $1.79M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $653.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $1.60M derived: sum of 2 quarters · filed 2026-03-16 | $3.02M derived: sum of 3 quarters · filed 2026-08-05 | $2.44M 10-K · filed 2026-03-16 | |
| 2025-09-30 | $946.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $2.36M derived: sum of 2 quarters · filed 2026-08-05 | $1.78M 10-Q · filed 2025-11-04 | $1.70M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | $1.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $838.00K 10-Q · filed 2026-08-05 | $750.00K derived: sum of 3 quarters · filed 2026-08-05 | -$1.44M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | -$578.00K 10-Q · filed 2026-05-06 | -$666.00K derived: sum of 2 quarters · filed 2026-05-06 | -$2.86M derived: sum of 3 quarters · filed 2026-05-06 | -$3.27M derived: sum of 4 quarters · filed 2026-05-06 | |
| 2024-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$2.28M derived: sum of 2 quarters · filed 2026-03-16 | -$2.69M derived: sum of 3 quarters · filed 2026-03-16 | -$12.97M 10-K · filed 2026-03-16 | |
| 2024-09-30 | -$2.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$2.60M derived: sum of 2 quarters · filed 2025-11-04 | -$12.89M 10-Q · filed 2025-11-04 | -$10.79M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-06-30 | -$410.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | -$10.69M 10-Q · filed 2025-08-15 | -$8.59M derived: sum of 3 quarters · filed 2026-03-16 | -$7.30M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2024-03-31 | -$10.28M 10-Q · filed 2025-05-06 | -$8.18M derived: sum of 2 quarters · filed 2026-03-16 | -$6.89M derived: sum of 3 quarters · filed 2026-03-16 | -$6.83M derived: sum of 4 quarters · filed 2026-03-16 | |
| 2023-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $3.39M derived: sum of 2 quarters · filed 2026-03-16 | $3.45M derived: sum of 3 quarters · filed 2026-03-16 | $1.62M 10-K · filed 2026-03-16 | |
| 2023-09-30 | $1.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $1.35M derived: sum of 2 quarters · filed 2024-11-06 | -$484.00K 10-Q · filed 2024-11-06 | -$1.76M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-06-30 | $61.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.77M 10-Q · filed 2024-08-06 | -$3.05M derived: sum of 3 quarters · filed 2025-03-11 | -$2.84M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2023-03-31 | -$1.83M 10-Q · filed 2024-05-09 | -$3.11M derived: sum of 2 quarters · filed 2025-03-11 | -$2.90M derived: sum of 3 quarters · filed 2025-03-11 | -$6.52M derived: sum of 4 quarters · filed 2025-03-11 | |
| 2022-12-31 | -$1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | -$1.06M derived: sum of 2 quarters · filed 2025-03-11 | -$4.68M derived: sum of 3 quarters · filed 2025-03-11 | -$2.78M 10-K · filed 2025-03-11 | |
| 2022-09-30 | $211.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$3.41M derived: sum of 2 quarters · filed 2023-11-07 | -$1.50M 10-Q · filed 2023-11-07 | -$1.63M derived: sum of 4 quarters · filed 2023-11-07 | |
| 2022-06-30 | -$3.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | -$1.71M 10-Q · filed 2023-08-08 | -$1.84M derived: sum of 3 quarters · filed 2023-08-08 | -$2.33M derived: sum of 4 quarters · filed 2023-08-08 | |
| 2022-03-31 | $1.91M 10-Q · filed 2023-05-09 | $1.77M derived: sum of 2 quarters · filed 2023-05-09 | $1.28M derived: sum of 3 quarters · filed 2023-05-09 | -$177.00K derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | -$131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$622.00K derived: sum of 2 quarters · filed 2023-03-14 | -$2.08M derived: sum of 3 quarters · filed 2023-03-14 | $1.28M 10-K · filed 2023-03-14 | |
| 2021-09-30 | -$491.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$1.95M derived: sum of 2 quarters · filed 2022-11-09 | $1.41M 10-Q · filed 2022-11-09 | -$228.00K derived: sum of 4 quarters · filed 2022-11-09 | |
| 2021-06-30 | -$1.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $1.90M 10-Q · filed 2022-08-09 | $263.00K derived: sum of 3 quarters · filed 2022-08-09 | $2.12M derived: sum of 4 quarters · filed 2022-08-09 | |
| 2021-03-31 | $3.36M 10-Q · filed 2022-05-09 | $1.72M derived: sum of 2 quarters · filed 2022-05-09 | $3.58M derived: sum of 3 quarters · filed 2022-05-09 | $3.60M derived: sum of 4 quarters · filed 2022-05-09 | |
| 2020-12-31 | -$1.64M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $220.00K derived: sum of 2 quarters · filed 2022-03-08 | $232.00K derived: sum of 3 quarters · filed 2022-03-08 | $3.36M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $1.87M derived: sum of 2 quarters · filed 2021-11-09 | $5.00M 10-Q · filed 2021-11-09 | $5.18M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-06-30 | $12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $3.14M 10-Q · filed 2021-08-06 | $3.32M derived: sum of 3 quarters · filed 2022-03-08 | $484.00K derived: sum of 4 quarters · filed 2022-03-08 | |
| 2020-03-31 | $3.12M 10-Q · filed 2021-05-07 | $3.31M derived: sum of 2 quarters · filed 2022-03-08 | $472.00K derived: sum of 3 quarters · filed 2022-03-08 | $1.26M derived: sum of 4 quarters · filed 2022-03-08 | |
| 2019-12-31 | $182.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$2.65M derived: sum of 2 quarters · filed 2022-03-08 | -$1.86M derived: sum of 3 quarters · filed 2022-03-08 | $787.00K 10-K · filed 2022-03-08 | $2.15M 10-K · filed 2020-02-27 |
| 2019-09-30 | -$2.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$2.04M derived: sum of 2 quarters · filed 2020-11-09 | $605.00K 10-Q · filed 2020-11-09 | -$1.74M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $790.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.44M 10-Q · filed 2020-08-07 | $1.09M derived: sum of 3 quarters · filed 2021-02-25 | $700.00K derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $2.65M 10-Q · filed 2020-05-11 | $301.00K derived: sum of 2 quarters · filed 2021-02-25 | -$90.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.39M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | -$2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$2.74M derived: sum of 2 quarters · filed 2021-02-25 | -$1.26M derived: sum of 3 quarters · filed 2021-02-25 | -$294.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | -$391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $1.08M derived: sum of 2 quarters · filed 2019-11-08 | $2.05M 10-Q · filed 2019-11-08 | $1.56M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $2.44M 10-Q · filed 2019-08-07 | $1.95M derived: sum of 3 quarters · filed 2020-02-27 | $2.78M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $970.00K 10-Q · filed 2019-05-07 | $476.00K derived: sum of 2 quarters · filed 2020-02-27 | $1.31M derived: sum of 3 quarters · filed 2020-02-27 | $1.39M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $337.00K derived: sum of 2 quarters · filed 2020-02-27 | $423.00K derived: sum of 3 quarters · filed 2020-02-27 | $585.00K 10-K · filed 2020-02-27 | |
| 2017-09-30 | $831.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $917.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.08M 10-Q · filed 2018-11-06 | $251.00K derived: sum of 4 quarters · filed 2019-03-18 | |
| 2017-06-30 | $86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $248.00K 10-Q · filed 2018-08-08 | -$580.00K derived: sum of 3 quarters · filed 2019-03-18 | -$1.04M derived: sum of 4 quarters · filed 2019-03-18 | |
| 2017-03-31 | $162.00K 10-Q · filed 2018-05-08 | -$666.00K derived: sum of 2 quarters · filed 2019-03-18 | -$1.13M derived: sum of 3 quarters · filed 2019-03-18 | -$508.00K derived: sum of 4 quarters · filed 2019-03-18 | |
| 2016-12-31 | -$828.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | -$1.29M derived: sum of 2 quarters · filed 2019-03-18 | -$670.00K derived: sum of 3 quarters · filed 2019-03-18 | -$2.27M 10-K · filed 2019-03-18 | |
| 2016-09-30 | -$463.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $158.00K derived: sum of 2 quarters · filed 2017-11-07 | -$1.44M 10-Q · filed 2017-11-07 | -$1.38M derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-06-30 | $621.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$980.00K 10-Q · filed 2017-08-08 | -$913.00K derived: sum of 3 quarters · filed 2018-03-08 | -$662.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2016-03-31 | -$1.60M 10-Q · filed 2017-05-09 | -$1.53M derived: sum of 2 quarters · filed 2018-03-08 | -$1.28M derived: sum of 3 quarters · filed 2018-03-08 | -$320.00K derived: sum of 4 quarters · filed 2018-03-08 | |
| 2015-12-31 | $67.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $318.00K derived: sum of 2 quarters · filed 2018-03-08 | $1.28M derived: sum of 3 quarters · filed 2018-03-08 | $769.00K 10-K · filed 2018-03-08 | |
| 2015-09-30 | $251.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $1.21M derived: sum of 2 quarters · filed 2016-11-09 | $702.00K 10-Q · filed 2016-11-09 | -$644.00K derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-06-30 | $963.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $451.00K 10-Q · filed 2016-08-09 | -$895.00K derived: sum of 3 quarters · filed 2017-03-03 | -$1.63M derived: sum of 4 quarters · filed 2017-03-03 | |
| 2015-03-31 | -$512.00K 10-Q · filed 2016-05-09 | -$1.86M derived: sum of 2 quarters · filed 2017-03-03 | -$2.59M derived: sum of 3 quarters · filed 2017-03-03 | -$2.92M derived: sum of 4 quarters · filed 2017-03-03 | |
| 2014-12-31 | -$1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | -$2.08M derived: sum of 2 quarters · filed 2017-03-03 | -$2.41M derived: sum of 3 quarters · filed 2017-03-03 | $107.00K 10-K · filed 2017-03-03 | |
| 2014-09-30 | -$730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$1.06M derived: sum of 2 quarters · filed 2015-11-09 | $1.45M 10-Q · filed 2015-11-09 | $2.10M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$331.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $2.18M 10-Q · filed 2015-08-10 | $2.83M derived: sum of 3 quarters · filed 2016-02-29 | $4.10M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | $2.51M 10-Q · filed 2015-05-11 | $3.17M derived: sum of 2 quarters · filed 2016-02-29 | $4.43M derived: sum of 3 quarters · filed 2016-02-29 | $3.19M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $652.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $1.92M derived: sum of 2 quarters · filed 2016-02-29 | $674.00K derived: sum of 3 quarters · filed 2016-02-29 | $1.80M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $22.00K derived: sum of 2 quarters · filed 2014-11-06 | $1.15M 10-Q · filed 2014-11-06 | $313.00K derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-06-30 | -$1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$116.00K 10-Q · filed 2014-08-04 | -$953.00K derived: sum of 3 quarters · filed 2015-02-26 | -$1.21M derived: sum of 4 quarters · filed 2015-02-26 | |
| 2013-03-31 | $1.13M 10-Q · filed 2014-05-12 | $291.00K derived: sum of 2 quarters · filed 2015-02-26 | $35.00K derived: sum of 3 quarters · filed 2015-02-26 | -$498.00K derived: sum of 4 quarters · filed 2015-02-26 | |
| 2012-12-31 | -$837.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | -$1.09M derived: sum of 2 quarters · filed 2015-02-26 | -$1.63M derived: sum of 3 quarters · filed 2015-02-26 | -$1.81M 10-K · filed 2015-02-26 | |
| 2012-09-30 | -$256.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$789.00K derived: sum of 2 quarters · filed 2013-11-07 | -$978.00K 10-Q · filed 2013-11-07 | -$1.96M derived: sum of 4 quarters · filed 2014-03-12 | |
| 2012-06-30 | -$533.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | -$722.00K 10-Q · filed 2013-08-07 | -$1.71M derived: sum of 3 quarters · filed 2014-03-12 | -$9.00K derived: sum of 4 quarters · filed 2014-03-12 | |
| 2012-03-31 | -$189.00K 10-Q · filed 2013-05-09 | -$1.17M derived: sum of 2 quarters · filed 2014-03-12 | $524.00K derived: sum of 3 quarters · filed 2014-03-12 | -$1.17M derived: sum of 4 quarters · filed 2014-03-12 | |
| 2011-12-31 | -$983.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $713.00K derived: sum of 2 quarters · filed 2014-03-12 | -$978.00K derived: sum of 3 quarters · filed 2014-03-12 | $540.00K 10-K · filed 2014-03-12 | |
| 2011-09-30 | $1.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $5.00K derived: sum of 2 quarters · filed 2012-11-09 | $1.52M 10-Q · filed 2012-11-09 | $2.87M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-06-30 | -$1.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$173.00K 10-Q · filed 2012-08-14 | $1.18M derived: sum of 3 quarters · filed 2013-03-12 | $1.14M derived: sum of 4 quarters · filed 2013-03-12 | |
| 2011-03-31 | $1.52M 10-Q · filed 2012-05-15 | $2.87M derived: sum of 2 quarters · filed 2013-03-12 | $2.83M derived: sum of 3 quarters · filed 2013-03-12 | ||
| 2010-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $1.32M derived: sum of 2 quarters · filed 2013-03-12 | $932.00K 10-K · filed 2013-03-12 | ||
| 2010-09-30 | -$35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | -$419.00K 10-Q · filed 2011-11-14 | |||
| 2010-06-30 | -$384.00K 10-Q · filed 2011-08-09 | ||||
| 2009-12-31 | -$637.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |